Cocrystal Pharma, Inc.

Home » Cocrystal Pharma, Inc.

Secondary

Cocrystal Pharma, Inc.

Cocrystal is a clinical stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases.

Symbol

COCP

Last Closing Price
$1.90

Shares
4,200,000

Anticipated Date
TBD

Underwriters
A.G.P.

To view the prospectus for Cocrystal Pharma, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253